Attendance at this conference will give you the opportunity to hear different approaches to immunotherapy and the latest data on performance in human clinical trials. Debate with key players on translational research and the EU Clinical Trials Directive, ensuring that scientists and doctors are striving towards the same endpoint

This exciting conference brings together an impressive group of experts working in the field of Cancer immunotherapy, including:

- Dr Neil Berinstein, Global director of Cancer Vaccine Programme, AVENTIS PASTEUR
- Dr. Cornelius Melief, Director of Leiden University Medical Centre, AVENTIS PASTEUR CANCER VACCINE PROGRAMME
- Professor Angus Dalgleish, Consultant in Oncology St Georges Medical School and Research Director of ONYVAX
- Professor Peter Stern, Head of Cancer Research UK Immunology Group, PATERSON RESEARCH INSTITUE FOR CANCER RESEARCH
- Dr Reiner Laus, Vice President of Research and Development, DENDREON CORPORATION
- Dr Axel Hoos, Head of Clinical Development, ANTIGENICS
- Dr Charles Nicolette, Vice President of Research, MERIX BIOSCIENCE INC.
- Dr Marnix Bosch, Vice President of Research and Development, NORTHWEST BIOTHERAPEUTICS
- Dr Christian Schetter, Vice president of European Operations, COLEY PHARMACEUTICALS
- Dr Alexander Eggermont, Head of Surgical Oncology, ERASMUS UNIVERSITY MEDICAL CENTRE